ALNY vs MVBF · P/E 76, rev $1.29B vs P/E 12, rev $93.4M
Alnylam Pharmaceuticals Inc (ALNY) versus MVB Financial Corp (MVBF) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
MVB Financial Corp (MVBF) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported MVBF revenue for 2026-06-30 was $93.4M. Net income was $17.4M. MVBF currently screens at market cap $337.7M and trailing P/E 12.1.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. MVBF currently screens at market cap $337.7M and trailing P/E 12.1.
Not investment advice. Open the ALNY and MVBF stock pages for the full models.
Not investment advice.